India · English
US FDA approves landmark pancreatic cancer drug Rasonque: Here's how much will it cost you
The FDA approved Rasonque (daraxonib) for advanced pancreatic cancer. Costs for the drug are not specified.
Read the full report at Livemint →
Also covered by
- BBC World: US drug agency approves breakthrough treatment for pancreatic cancer
- France 24: FDA approves new drug Rasonque to treat advanced pancreatic cancer
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.